Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation.

Subjects

Subjects :

Acetates
Calcineurin Inhibitors therapeutic use
Humans
Quinazolines
Graft vs Host Disease drug therapy
Graft vs Host Disease etiology
Graft vs Host Disease prevention & control
Hematopoietic Stem Cell Transplantation adverse effects

Details

Language :

English

ISSN :

2473-9537

Volume :

6

Issue :

10

Database :

MEDLINE

Journal :

Blood advances

Publication Type :

Academic Journal

Accession number :

35078219

Full Text :

https://doi.org/10.1182/bloodadvances.2021006213